Learn about colorectal cancer, its risk factors, symptoms, and the latest treatment options. Early detection through ...

Merck & Co.’s said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet ...

Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Japanese Ministry of Health, Labour and ...

Disruption of the circadian clock may accelerate the progression of colorectal cancer by affecting the gut microbiome and ...

Research has revealed how disruption of the circadian clock, the body's internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and ...

Dietary Change Starves Cancer Cells, Overcoming Treatment Resistance Nov. 18, 2022 — A dietary change could be a key to enhancing colon cancer treatment, a new study finds. Researchers found in ...

Doctors are increasingly noticing a troubling trend: more young people under the age of 50 are being diagnosed with ...

After facing colorectal cancer for nearly eight years, Mandy Wilk got a double-lung transplant in June at Northwestern. She ...

Colon Cancer or Colorectal Cancer (CRC ... Surgery may be combined with adjuvant therapy, which is treatment before or after surgery. Additional treatments, especially for cancer that has spread ...

Silexion Therapeutics' stock surged after the company revealed preclinical findings for SIL-204, its siRNA candidate.

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

A new, comprehensive study has uncovered critical insights into the genetic makeup of colorectal cancer (CRC), providing a ...